PT  - JOURNAL ARTICLE
AU  - Al-Rakhami, Mabrook S.
AU  - Islam, Md. Milon
AU  - Islam, Md. Zabirul
AU  - Asraf, Amanullah
AU  - Sodhro, Ali Hassan
AU  - Ding, Weiping
TI  - Diagnosis of COVID-19 from X-rays Using Combined CNN-RNN Architecture with Transfer Learning
AID  - 10.1101/2020.08.24.20181339
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2020.08.24.20181339
4099  - http://medrxiv.org/content/early/2021/08/09/2020.08.24.20181339.short
4100  - http://medrxiv.org/content/early/2021/08/09/2020.08.24.20181339.full
AB  - The confrontation of COVID-19 pandemic has become one of the promising challenges of the world healthcare. Accurate and fast diagnosis of COVID-19 cases is essential for correct medical treatment to control this pandemic. Compared with the reverse-transcription polymerase chain reaction (RT-PCR) method, chest radiography imaging techniques are shown to be more effective to detect coronavirus. For the limitation of available medical images, transfer learning is better suited to classify patterns in medical images. This paper presents a combined architecture of convolutional neural network (CNN) and recurrent neural network (RNN) to diagnose COVID-19 from chest X-rays. The deep transfer techniques used in this experiment are VGG19, DenseNet121, InceptionV3, and Inception-ResNetV2. CNN is used to extract complex features from samples and classified them using RNN. The VGG19-RNN architecture achieved the best performance among all the networks in terms of accuracy in our experiments. Finally, Gradient-weighted Class Activation Mapping (Grad-CAM) was used to visualize class-specific regions of images that are responsible to make decision. The system achieved promising results compared to other existing systems and might be validated in the future when more samples would be available. The experiment demonstrated a good alternative method to diagnose COVID-19 for medical staff.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNone.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All the guidelines are followed properly.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data will be available on request.